Delivery Order SPE2DB22D3016-SPE2DB24FAJJ9
- Not listed
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of 4,562,139,657 units of Naloxone HCl 4 mg Nasal Spray, a critical medication used for the treatment of opioid overdose. The contract has a ceiling value of $1,199.86 and a completion date of September 13, 2023. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,559,464,440 units of 4 mg Naloxone HCl nasal spray, a critical medication used to treat opioid overdoses. The contract has a ceiling value of $2,737.24 and an ultimate completion date of December 29, 2022. This award is part of a larger Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Naloxone HCl 4 mg nasal spray, a critical medication used to reverse opioid overdose. The contract has a ceiling value of $3,313.76 and will run through January 29, 2025. It is a firm fixed-price contract, with no set-aside designation. Amerisourcebergen holds a significant...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,767,954 units of Naloxone HCL 4 mg Nasal Spray 2S, a critical medication used to reverse opioid overdoses. The contract has a ceiling value of $1,626.00 and a completion date of July 14, 2025. The contract is not set-aside and was awarded on July 11, 2025....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Naloxone HCL 4 mg nasal spray, a medication used to treat opioid overdose. The contract has a firm fixed price of $6,712.94 and a performance period through May 8, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,560,986,360 units of Naloxone HCl 4 mg Nasal Spray 2S, a medication used to treat opioid overdose. The contract has a ceiling value of $7,085.57 and an ultimate completion date of May 19, 2023. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that plays a...
- This federal contract award, valued at $1,838.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,999,320 units of Naloxone HCl 4 mg Nasal Spray, a critical medication used to treat opioid overdoses. This delivery order contract has a firm fixed-price pricing type and an ultimate completion date of April 23, 2025. Amerisourcebergen Drug Corp also...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,560,983,291 units of Naloxone HCL 4 mg Nasal Spray. The delivery order, valued at $1,845.84, has a firm fixed-price and is expected to be completed by May 19, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,342.40 firm fixed price contract is for the delivery of 4 mg naloxone hydrochloride nasal spray, a critical medication used to reverse opioid overdoses. The contract has a period of performance through March 2025 and is not designated as a set-aside award. AmerisourceBergen holds a significant $999,999,999 Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,999.85, is for the delivery of 4,563,244,442 units of Naloxone HCL 4 mg Nasal Spray. The contract is a Firm Fixed Price Delivery Order with a period of performance through January 8, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FAJJ9Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,324,180 units of Naloxone HCL 4 mg Nasal Spray, an opioid overdose reversal medication. The contract has a ceiling value of $8,728.30 and a period of performance through January 16, 2024. The contract was awarded on a firm fixed-price basis and was not subject to any set-aside requirements. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.7k | 1/12/24 |